Literature DB >> 18368420

Mechanism by which rHuEPO improves submaximal exercise performance.

T D Noakes.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18368420     DOI： 10.1007/s00421-008-0712-z

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN： 1439-6319            Impact factor:   3.078


× No keyword cloud information.
  1 in total

1.  Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.

Authors:  J J Thomsen; R L Rentsch; P Robach; J A L Calbet; R Boushel; P Rasmussen; C Juel; C Lundby
Journal:  Eur J Appl Physiol       Date:  2007-08-01       Impact factor: 3.078
  1 in total
  2 in total

1.  EPO and doping.

Authors:  Costantino Balestra; Peter Germonpré
Journal:  Eur J Appl Physiol       Date:  2010-03-14       Impact factor: 3.078

2.  Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.

Authors:  Jérôme Durussel; Evangelia Daskalaki; Martin Anderson; Tushar Chatterji; Diresibachew H Wondimu; Neal Padmanabhan; Rajan K Patel; John D McClure; Yannis P Pitsiladis
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.